We are live on ! Find out more
VNRX icon

VolitionRx Ltd

26 hedge funds and large institutions have $4.84M invested in VolitionRx Ltd in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

8% more funds holding

Funds holding: 2426 (+2)

0.01% more ownership

Funds ownership: 0.47%0.48% (+0.01%)

18% less capital invested

Capital invested by funds: $5.89M → $4.84M (-$1.06M)

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
7
Reduced
6
Closed
4
Calls
$33K
Puts
Net Calls
+$33K
Net Calls Change
+$2K
Name Holding Trade Value Shares
Change
Change in
Stake
SAMC
26
Spectrum Asset Management (California)
California
-$42.1K -2,780 Closed
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
-$36.7K -2,504 Closed
TSS
28
Two Sigma Securities
New York
-$17.2K -1,134 Closed
Wells Fargo
29
Wells Fargo
California
-$359 -24 Closed
Simplex Trading
30
Simplex Trading
Illinois
-$117 -8 -33%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
+$29 +2 +100%

VNRX Hedge Fund Activity: Q2 2024 in Review

26 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2024, worth a combined $4.84M — down 18% from $5.89M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new VNRX positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Lagoda Investment Management, adding an estimated $267K. The largest seller was BlackRock, cutting an estimated $42.2K.

  • 26 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2024, up from 24 in Q1 2024.
  • Funds reported $4.84M of VolitionRx Ltd stock for Q2 2024, down 18% quarter-over-quarter.
  • 6 funds opened new VolitionRx Ltd positions in Q2 2024 and 4 closed out, a net change of +2 holders.
  • The largest VolitionRx Ltd buyer in Q2 2024 was Lagoda Investment Management, an estimated $267K added.
  • The largest VolitionRx Ltd seller in Q2 2024 was BlackRock, an estimated $42.2K sold.

Based on aggregated 13F filings for Q2 2024.